| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 669821 | Null | 0.0295480456086947 | 0.093027767 |
| NSC 670664 | Null | 0.0295480456086947 | 0.15421054 |
| NSC 670765 | Null | 0.0295480456086947 | 0.2887738 |
| NSC 676914 | 2-(4-((4-amino-2-methylphenyl)diazenyl)phenylsulfonyl)ethanesulfonoperoxoic acid | 0.0295480456086947 | 0.22723678 |
| NSC 678925 | 1-Phenazinecarboxamide, N-[2-(dimethylamino)ethyl]- 9-fluoro-, monohydrochloride | 0.0295480456086947 | 0.12764721 |
| NSC 679001 | 2-Butenedioic acid, 2-[3-[(ethoxycarbonyl)methyl]-2,4-dioxopyrimidin-1-yl-, diethyl ester, (E)- | 0.0295480456086947 | 0.49525278 |
| NSC 681645 | Camptothecin Derivative | 0.0295480456086947 | 0.083181546 |
| NSC 682011 | Benzimidazo[1,2-b]isoquinoline-6-carbonitrile, 7,8,9,10-tetrahydro-11-[(4-fluorophenyl)amino]- | 0.0295480456086947 | 0.1122845 |
| NSC 686940 | Null | 0.0295480456086947 | 0.23495396 |
| NSC 687305 | 4-(N-acetyl-N-ethylamino)isoquinoline-1-carboxaldehyde thiosemicarbazone | 0.0295480456086947 | -0.08603214 |